Abstract
BackgroundThe pathway from discovery to clinical adoption of predictive spatial biomarkers (spatial signatures) for immunotherapy response requires a solution that bridges ultrahigh-plex discovery experiments with targeted high-throughput translational and clinical...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have